Rosacea

Journey Medical, Dr. Reddy’s to Commercialize and Develop DFD-29 for Rosacea
July 09, 2021

Journey Medical Corporation and Dr. Reddy’s Laboratories Ltd. have joined forces for the development and commercialization of DFD-19 as a treatment for rosacea.

Dermoscopy Falls Short in Diagnosing Demodex
July 02, 2021

Dermoscopy cannot diagnose D folliculorum proliferation but can reveal specific findings in patients with papulopustular rosacea.

What’s New in Acne and Rosacea for 2021?
June 15, 2021

Emmy Graber, MD, presented the updates in acne and rosacea treatments at the SCALE Acne and Rosacea update on June 9, 2021.

OTC Skin Care Products Enhance Rosacea Therapy
May 25, 2021

Nonprescription moisturizers and cleansers can play an integral role in delivering positive treatment outcomes for patients with rosacea.

Off-label Sarecycline Combats Papulopustular Rosacea
May 11, 2021

Recent therapeutic advances in topical and systemic therapy offer new options for cases that have not responded to established treatment approaches.

Neuromodulators Combat Key Rosacea Challenges
April 22, 2021

In treatments addressing muscular contraction, botulinum toxin inhibits nerves that innervate blood vessels from releasing acetylcholine, which triggers vasodilation. Its impact on the innate immune system suggests that botulinum toxin may also help reduce recalcitrant rosacea-related papules and pustules.

2021 Rosacea Report
April 06, 2021

New treatments continue to expand therapy options, but a cure remains elusive.

Collagen Degeneration Linked to Rosacea
March 25, 2021

Findings from a recent study indirectly support therapeutic approaches aimed at restoring the dermal matrix.

New E-BPO Improves Rosacea
March 16, 2021

This formulation could be first FDA-approved single-agent E-BPO prescription drug to treat rosacea.

Study: Mask Usage Worsens Rosacea
March 11, 2021

Recent research shows prolonged face-mask usage leads to negative quality-of-life impact and worsening of disease for rosacea.